Key statistics
On Friday, Oncolytics Biotech Inc (ONYN:BER) closed at 0.80, 6.67% above its 52-week low of 0.75, set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.80 |
---|---|
High | 0.80 |
Low | 0.80 |
Bid | 0.78 |
Offer | 0.92 |
Previous close | 0.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 77.04m |
Free float | 74.10m |
P/E (TTM) | -- |
Market cap | 99.38m CAD |
EPS (TTM) | -0.3827 CAD |
Data delayed at least 15 minutes, as of Sep 20 2024 07:14 BST.
More ▼
Press releases
- Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
- Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September
- Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference
- Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights
- Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
- Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program
- Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence
More ▼